We are live on ! Find out more
VINC

Vincerx Pharma, Inc. Common Stock
VINC

Delisted

VINC was delisted on the 22nd of April, 2025.

Back to rankings

Fund managers haven’t disclosed any holdings of VINC yet.

VINC Hedge Fund Activity: Q3 2025 in Review

0 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Vincerx Pharma, Inc. Common Stock (VINC) for Q3 2025, worth a combined $0 — down 100% from $2 a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of VINC and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Bank & Trust Company, exiting entirely with an estimated $2 sold.

  • 0 institutional investors held Vincerx Pharma, Inc. Common Stock (VINC) as of Q3 2025, down from 1 in Q2 2025.
  • Funds reported $0 of Vincerx Pharma, Inc. Common Stock stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Vincerx Pharma, Inc. Common Stock positions in Q3 2025 and 1 closed out, a net change of -1 holder.
  • The largest Vincerx Pharma, Inc. Common Stock seller in Q3 2025 was Bank & Trust Company, an estimated $2 sold.

Based on aggregated 13F filings for Q3 2025.